Most Read Articles
3 days ago
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Jairia Dela Cruz, 3 days ago
The selective serotonin reuptake inhibitor escitalopram holds promise in the prevention of Alzheimer’s disease, reducing amyloid-β-42 levels in cerebrospinal fluid and brain tissue in older adults with normal cognitive function, according to recent evidence.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Shorter penile implants fit for prostatectomy-induced erectile dysfunction

18 Nov 2020

Patients with erectile dysfunction (ED) due to postradical prostatectomy (PRP) seem to require penile implants with shorter cylinders than ED patients whose primary aetiology is vasculogenic in nature, a recent study has found.

Aside from cylinder size, both patient groups have largely comparable implant needs and procedure outcomes.

The study included 117 patients who received virgin implants for ED; 58 had PRP as an aetiology, while 59 developed ED due to vasculogenic causes. All patients had a minimum follow-up of 6 months. The primary study outcome was cylinder and tip size, while procedural factors, such as complications and fibrosis, were set as secondary endpoints.

Cylinder size differed between the two patient groups. Those who had PRP as their primary ED aetiology received larger cylinders, with an average size of 18.30±2.11 cm, as opposed to vasculogenic ED patients, whose average implant cylinder size was 19.21±1.71 cm (p=0.016).

Other variables were comparable between groups. The type of prosthesis used did not differ between aetiology groups, and neither did the prevalence of cavernosal fibrosis requiring vigorous dilatation. The use of cavernotomes was likewise comparable between groups, as was the occurrence of intraoperative complications.

In addition, the researchers likewise found that postoperative complications such as infections, mechanical failures, and extrusions occurred at similar frequencies between groups. Patients were followed for an average of 67.75 months.

Editor's Recommendations
Most Read Articles
3 days ago
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Jairia Dela Cruz, 3 days ago
The selective serotonin reuptake inhibitor escitalopram holds promise in the prevention of Alzheimer’s disease, reducing amyloid-β-42 levels in cerebrospinal fluid and brain tissue in older adults with normal cognitive function, according to recent evidence.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.